Plethora Solutions PLC
http://www.plethorasolutions.co.uk/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Plethora Solutions PLC
Finance Watch: AltruBio, Pheon Raise Venture Capital Mega-Rounds
Private Company Edition: AltruBio raised up to $225m and Pheon garnered $120m in series B financings, while Lycia brought in $106.6m in series C cash. Also, Sands Capital closed its third life science fund, totaling $555m, and NewVale Capital debuted with $167m for life science services.
GW Pharma's Cannabinoid Medicine Epidyolex Among CHMP Hopefuls
Seven new medicines, including GW Pharma's orphan cannabidiol product, Epidyolex, are due for an opinion from the European Medicines Agency this week on whether they should be recommended for pan-EU approval.
Appointments: Merck KGaA, Myovant, Scholar Rock, C4X Discovery, Paragon Bioservices and Gamida Cell.
This week's roundup includes appointments by Merck KGaA, C4X Discovery Holdings, Paragon Bioservices and board appointments by Scholar Rock, Myovant Sciences and Gamida Cell.
European Biotechs Mull Going To Market Without Big Pharma Partners
European biotech companies that have lead products turned down by big pharma are now considering the benefits of taking drugs through late-stage development themselves; more funding options, such as concluding an IPO in the U.S. or Europe, is driving some of this change.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Plethora Solutions Holdings plc
- The Urology Company Limited
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice